Both in Pharmaceuticals
NRX Pharmaceuticals vs Immunic
Over the past year NRXP returned −24.8% and IMUX returned −4.2%; their daily moves had a correlation of 0.05.
NRXP −24.8% IMUX −4.2%Growth of $1, one year, split-adjusted
| Metric | NRXP | IMUX |
|---|---|---|
| Price | $2.27 | $7.51 |
| Market cap | $98.3M | $102.5M |
| Today | −14.66% | −3.66% |
| 1 month | −20.4% | −13.1% |
| 6 months | −26.5% | −22.2% |
| Year to date | −16.2% | +40.7% |
| 1 year | −25.6% | −5.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | 38.7% | — |
| Net margin | −1500.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 29.0× | — |
| Net cash | $26.3M | $155.1M |
| Dividend yield | — | — |
| Volatility (60d) | 65.5% | 75.1% |
| Short % of float | 29.3% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).